Skip to content
AnalystLens

AFLAC INC Quarterly Report for Q1 Ended Mar 31, 2025

Filing Date
Filed May 7, 2025
Period End
March 31, 2025
Security
AFL
In the record · 2016–202610-K1110-Q328-K114

AFL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 114 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Oct ’17Oct ’17
  2. Leadership change8-K · Nov ’19Nov ’19
  3. Leadership change8-K · Dec ’23Dec ’23

Summary

Summary of the 10-Q filed May 7, 2025. Cited figures are marked; the original filing is the authoritative source.

Aflac Incorporated (AFL) reported a significant year-over-year decline in net earnings for the first quarter of 2025, primarily driven by a substantial shift from net investment gains in the prior year to net investment losses in the current quarter.

Net earnings were $29 milliona, or $0.05 per diluted share, compared to $1.9 billion, or $3.25 per diluted share, in the first quarter of 2024. This swing is largely attributable to mark-to-market movements in investments and derivatives, particularly a significant net investment loss of $963 million in Q1 2025 versus a net investment gain of $951 million in Q1 2024. Despite the sharp decline in reported net earnings, adjusted earnings, which exclude certain volatile investment and foreign currency impacts, were $906 million, or $1.66 per diluted share, a slight decrease from $961 million, or $1.66 per diluted share, in the prior year.

The company's operations in Japan, Aflac Japan, continue to be the larger segment, though yen weakening impacted dollar-denominated results. Aflac U.S. showed modest growth in net earned premiums and maintained stable profitability. The company continued its share repurchase program, returning $900 millionb to shareholders in the quarter.

Shareholders' equity saw an increase, largely due to positive impacts from changes in discount rate assumptions on insurance reserves, although offset by unrealized losses on investments and foreign currency translation. Investors should focus on the adjusted earnings and operational performance metrics, as the reported net earnings are heavily influenced by market volatility.

The company's core insurance business, particularly in Japan, remains robust, demonstrating resilience despite challenging investment market conditions. The continued share buybacks signal management's confidence in the company's underlying financial health.

Key Highlights

  1. Net earnings for Q1 2025 significantly decreased to $29 million ($0.05/share) from $1.9 billion ($3.25/share) in Q1 2024, primarily due to a swing from net investment gains to net investment losses.
  2. Adjusted earnings were $906 million ($1.66/share), a slight decrease from $961 million ($1.66/share) in Q1 2024, indicating resilient underlying operational performance.
  3. Aflac Japan segment's pretax adjusted earnings decreased by 10.9% year-over-year, impacted by lower net earned premiums and adjusted net investment income, partially offset by lower benefits and claims.
  4. Aflac U.S. segment's pretax adjusted earnings saw a slight increase of 0.6% year-over-year, driven by higher net earned premiums and improved expense efficiency, which offset higher benefits and claims.
  5. The company repurchased $900 million of its common stock in Q1 2025, underscoring its commitment to returning capital to shareholders.
  6. Shareholders' equity increased to $26.3 billion ($48.55/share) at March 31, 2025, from $26.1 billion ($47.45/share) at December 31, 2024, boosted by favorable changes in discount rate assumptions on insurance reserves.
  7. The company maintains strong capital positions in both its Japanese and U.S. segments, with Aflac Japan's Solvency Margin Ratio (SMR) and Aflac U.S.'s Risk-Based Capital (RBC) ratio remaining robust.

Financial Statements

Q1 FY2025 against Q1 FY2024

Line itemQ1 FY2025Q1 FY2024Change
Revenue$3.40B$5.44B−37.5%
SG&A Expenses$802.00M$739.00M+8.5%
Operating Expenses$1.31B$1.26B+4.1%
Interest Expense$49.00M$46.00M+6.5%
Net Income$29.00M$1.88B−98.5%
EPS (Basic)$0.05$3.27−98.5%
EPS (Diluted)$0.05$3.25−98.5%
Shares Outstanding (Basic)544.71M574.89M−5.2%
Shares Outstanding (Diluted)546.88M577.48M−5.3%

Frequently Asked Questions

  1. What caused the significant drop in net earnings compared to the previous year?

    The substantial decrease in net earnings from $1.9 billion in Q1 2024 to $29 million in Q1 2025 was primarily due to a significant swing in net investment results. The company experienced net investment losses of $963 million in Q1 2025, compared to net investment gains of $951 million in Q1 2024. This volatility is largely attributed to mark-to-market fluctuations in the company's investment portfolio and derivative instruments.

  2. How did the company's core insurance operations perform, excluding investment volatility?

    Excluding investment gains/losses and other non-recurring items, Aflac's adjusted earnings were $906 million ($1.66 per diluted share) for Q1 2025, a slight decrease from $961 million ($1.66 per diluted share) in Q1 2024. This indicates that the core insurance operations remained relatively stable, with Aflac Japan showing a slight operational decline and Aflac U.S. demonstrating slight operational improvement.

  3. What is the outlook for Aflac Japan, given its significance to the company's results?

    Aflac Japan's pretax adjusted earnings decreased by 10.9% year-over-year, primarily due to lower net earned premiums (partially from an internal reinsurance transaction and limited-pay products reaching premium paid-up status) and a decrease in adjusted net investment income. Despite this, the segment's operational performance remains a key focus, with new annualized premium sales showing a slight increase in yen terms, driven by specific product sales and digital sales initiatives. The company continues to manage currency risk and maintain strong solvency margins in Japan.

  4. How is the company managing its capital and returning value to shareholders?

    Aflac returned $900 million to shareholders in Q1 2025 through share repurchases, continuing its buyback program. Shareholders' equity saw an increase, reflecting positive impacts from changes in discount rate assumptions on insurance reserves, although this was partially offset by unrealized investment losses. The company maintains strong capital levels across its segments, aiming for robust solvency and financial strength.